Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine research network awarded £1.2 million grant
The network has members in 93 countries.
The network supports livestock and zoonotic vaccine research.

The International Veterinary Vaccinology Network (IVVN), based at the Roslin Institute, has been awarded a £1.2 million grant from the Medical Research Council.

The network, which is made up of more than 1,900 scientists and industry partners from 93 countries around the world, aims to help develop improved vaccines for livestock and zoonotic diseases.

It is one of five global vaccine networks which provide a collaborative platform for researchers, particularly from low and middle income countries, to share knowledge and expertise.
 
The funding will allow IVVN to provide funding for collaboration between scientists, offer training opportunities, and engage the next generation of scientists.

Dr Timothy Connelley, network director of IVVN, said: “We are delighted to have been awarded funding to continue our activities to support veterinary vaccinologists across the world.

“With this funding, we will continue efforts to bring the human and veterinary vaccine research communities together, support scientific collaboration by providing pump-priming funding, provide training for early career researchers and expand our schools outreach programme to inspire the next generation of scientists.”

Dr Mark Palmer, director of international strategy at the Medical Research Council, said: “Investing in collaborations like these will better prepare us for future disease epidemics and to more effectively tackle the slow-moving pandemic of antimicrobial resistance.

“These global networks are integral to ensuring the UK harnesses the extraordinary potential of research and innovation to enrich and improve the lives of people living in the UK and around the world.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.